bluebird bio Inc. (NASDAQ: BLUE)
$8.4050
-0.8250 ( -8.64% ) 512.5K
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$8.4050
Previous close
$9.2300
Volume
512.5K
Market cap
$89.74M
Day range
$8.2010 - $9.7630
52 week range
$5.8000 - $38.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Nov 08, 2024 |
4 | Insider transactions | 2 | Nov 08, 2024 |
4 | Insider transactions | 2 | Nov 08, 2024 |
8-k | 8K-related | 13 | Nov 06, 2024 |
8-k | 8K-related | 13 | Oct 04, 2024 |
4 | Insider transactions | 2 | Oct 02, 2024 |
4 | Insider transactions | 1 | Oct 02, 2024 |
4 | Insider transactions | 2 | Oct 02, 2024 |
4 | Insider transactions | 2 | Oct 02, 2024 |
4 | Insider transactions | 2 | Oct 02, 2024 |